1. Discovered an efficient, patent-pending bacterial biosynthesis process for tryptamine production.

2. Developing a portfolio of tryptamine-derived, psychedelically inspired molecules.

3. Demonstrated the entourage effect of certain tryptamines in a laboratory-controlled environment.

Paradigm Shift for Treating Mental Illness and Neurological Disorders

News Title

Date

I'm a paragraph. I'm connected to your collection through a dataset. Click Preview to see my content. To update me, go to the Data Manager.

News Title

Date

I'm a paragraph. I'm connected to your collection through a dataset. Click Preview to see my content. To update me, go to the Data Manager.

News Title

Date

I'm a paragraph. I'm connected to your collection through a dataset. Click Preview to see my content. To update me, go to the Data Manager.

Menu:

About Us:

PsyBio Therapeutics is developing biosynthetic psychoactive compounds which offer a new paradigm of treatment to reverse the course of mental health issues.

Investment Deck:

© 2020 by PSYBIO